Device Trial Radar · NCT04900844
Safety and Efficacy of the CGuard™ Carotid Stent System in Carotid Artery Stenting
Last checked: Nov 20, 2026Latest source record: Apr 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
317
Actual
Start
Jul 1, 2021
Primary completion
Jul 1, 2022
Study completion Oct 1, 2025
Sponsor
- Lead sponsor
- InspireMDNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 25, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 19 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this pivotal study is to evaluate the safety and efficacy of the CGuard™ Carotid Stent System in the treatment of carotid artery stenosis in symptomatic and asymptomatic patients undergoing carotid artery stenting (CAS) to a performance goal developed from published CAS literature.
Conditions
- Carotid Artery Stenosis
Interventions
CGuard Carotid Stent implantationDevice
Implantation of CGuard carotid stent in the eligible patients
Primary outcomes
What the sponsor says the trial is designed to measure.
- Composite of DSMI through 30 days or ipsilateral stroke 31 - 365 days post-index procedureTime frame: From index procedure to 1 year follow up
Locations
18 sites in 2 countries. Site status is shown where the registry gives one.
University of Florida
Jacksonville, Florida
Oschner Health
New Orleans, Louisiana
Ascension, St. John Hospital
Detroit, Michigan
15 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.